- Published on
Clinical Toxicology — Smoke Inhalation
1. Overview
Smoke inhalation injury encompasses thermal injury, chemical irritation, particulate injury, oxygen deprivation, and poisoning by gases generated during combustion.
It is a major contributor to illness and death associated with fires, particularly fires occurring in enclosed spaces.
The severity of exposure depends on the materials burning, combustion conditions, ventilation, duration of exposure, and underlying health of the patient.
Smoke inhalation can produce three overlapping types of injury:
- Upper-airway injury: Thermal or chemical injury causing swelling and possible obstruction.
- Lower-respiratory injury: Chemical inflammation, bronchospasm, airway cast formation, impaired gas exchange, and acute respiratory distress syndrome.
- Systemic poisoning: Particularly carbon monoxide and cyanide poisoning, which impair oxygen transport or cellular oxygen utilization.
A patient may have serious inhalation injury without visible external burns.
Conversely, facial burns or singed nasal hair do not necessarily indicate severe internal airway injury.
The immediate priorities are removal from exposure, 100% oxygen, identification of threatened airway patency, and recognition of carbon monoxide or cyanide poisoning.
2. Combustion products
Smoke composition varies greatly according to the fuel, temperature, oxygen availability, and stage of combustion.
Carbon monoxide
Carbon monoxide is generated during incomplete combustion of carbon-containing materials.
It is particularly important in enclosed-space fires and causes impaired oxygen delivery and cellular injury.
Hydrogen cyanide
Hydrogen cyanide can be generated by burning nitrogen-containing materials, including polyurethane foam, wool, silk, nylon, and certain plastics.
It interferes with mitochondrial oxygen utilization.
Respiratory irritants
Common irritant products include:
- Acrolein.
- Formaldehyde.
- Ammonia.
- Hydrogen chloride.
- Hydrogen fluoride.
- Nitrogen oxides.
- Sulfur dioxide.
- Particulate matter.
These agents may injure airway epithelium, disrupt pulmonary defenses, and trigger inflammatory responses.
Additional compounds
Smoke may contain volatile organic compounds, aldehydes, metals, and other combustion products.
Some unusual industrial fires can also produce clinically important exposures to hydrogen sulfide or methemoglobin-forming substances.
Not all of these toxins are present at dangerous concentrations in every fire.
3. Pathophysiology
Thermal injury
Inhaled hot gases usually injure the upper respiratory tract, particularly the oropharynx and supraglottic structures.
Because heat is transferred efficiently in the upper airway, significant direct thermal injury below the vocal cords is relatively uncommon.
Superheated steam is an important exception because it can transfer substantial heat to deeper respiratory structures.
Upper-airway edema
Thermal and chemical injury increase vascular permeability and cause mucosal swelling.
Airway obstruction can develop progressively during the hours following exposure.
Lower-airway chemical injury
Particulates and irritant gases damage airway epithelium.
Inflammation leads to increased mucus production, impaired ciliary clearance, bronchospasm, and airway obstruction.
Bronchial cast formation
Excess mucus, fibrin, and damaged tissue can form obstructive airway casts.
These impair ventilation and contribute to atelectasis.
Alveolar injury
Inflammation and increased pulmonary capillary permeability may cause noncardiogenic pulmonary edema and acute respiratory distress syndrome.
Systemic asphyxiation
Carbon monoxide reduces effective oxygen transport and interferes with cellular function.
Cyanide prevents cells from using oxygen effectively.
These mechanisms can coexist and produce severe injury even when pulmonary imaging is initially normal.
4. Risk factors for severe injury
Important exposure features include:
- Fire in an enclosed or poorly ventilated space.
- Prolonged entrapment.
- Loss of consciousness.
- Exposure to dense smoke.
- Significant burns, particularly involving the face or neck.
- Evidence of respiratory distress.
- Altered mental status.
- Hypotension or shock.
- Known exposure to industrial chemicals.
Children may be particularly vulnerable because of smaller airway diameter.
Older adults and patients with cardiac or pulmonary disease may have less physiologic reserve.
Pregnancy adds important fetal considerations, particularly with carbon monoxide exposure.
5. Clinical manifestations
Upper-airway symptoms
Early findings may include throat pain, hoarseness, dysphonia, cough, and difficulty swallowing.
More concerning findings include:
- Stridor.
- Progressive hoarseness.
- Oropharyngeal swelling.
- Difficulty managing secretions.
- Respiratory distress.
External findings
Facial burns, singed nasal hairs, soot around the nose or mouth, and carbonaceous sputum may indicate significant smoke exposure.
However, these signs are not sufficiently sensitive or specific to determine airway injury severity by themselves.
Lower-respiratory symptoms
Patients may develop cough, wheezing, dyspnea, chest tightness, and tachypnea.
Hypoxemia may develop as lower-airway inflammation progresses.
Neurologic symptoms
Headache, dizziness, weakness, confusion, seizures, and coma may occur.
These findings should raise concern for carbon monoxide, cyanide, hypoxia, associated trauma, or another medical problem.
Cardiovascular findings
Tachycardia is common.
Severe poisoning may produce hypotension, myocardial ischemia, dysrhythmias, and cardiac arrest.
6. Delayed manifestations
Smoke inhalation injury is dynamic.
A patient may initially appear well but subsequently develop progressive airway swelling, bronchospasm, worsening oxygenation, or pulmonary edema.
Upper-airway deterioration
Airway edema can evolve over several hours.
The absence of stridor immediately after rescue does not establish that airway obstruction cannot develop.
Pulmonary deterioration
Lower-respiratory injury may become more apparent during the first 24–48 hours.
The initial chest radiograph may be normal.
Clinical implication
Patients with a concerning exposure history or evolving symptoms require repeated examinations rather than relying on a single reassuring assessment.
7. Carbon monoxide poisoning
Carbon monoxide binds to hemoglobin with much greater affinity than oxygen.
This reduces the blood’s capacity to transport oxygen.
Carbon monoxide also affects mitochondrial function and other cellular processes.
Clinical manifestations
Symptoms include headache, nausea, dizziness, weakness, confusion, syncope, and altered consciousness.
Severe cases can produce seizures, myocardial injury, coma, and death.
Carboxyhemoglobin testing
Carboxyhemoglobin (COHb) should be measured using laboratory co-oximetry.
Arterial or venous blood can be used.
Diagnostic interpretation
The CDC notes that COHb concentrations above approximately 2% in nonsmokers or 9% in smokers strongly support exposure.
However, concentrations must be interpreted with the history and clinical condition.
COHb decreases after removal from exposure, especially when oxygen has already been administered.
A normal or low measured COHb does not exclude serious earlier exposure.
Pulse oximetry pitfall
Conventional pulse oximeters cannot reliably distinguish oxyhemoglobin from carboxyhemoglobin.
A normal displayed oxygen saturation may therefore be misleading.
Likewise, a normal arterial oxygen partial pressure does not exclude carbon monoxide poisoning.
8. Treatment of carbon monoxide poisoning
Immediate oxygen
Administer 100% oxygen as soon as carbon monoxide poisoning is suspected.
Use an appropriate high-concentration delivery device or mechanical ventilation when clinically indicated.
Oxygen accelerates carbon monoxide elimination and improves tissue oxygen availability.
Duration
Continue high-concentration oxygen until symptoms have resolved and further treatment decisions have been made.
The CDC describes approximately four to five hours as a common treatment duration, although severe cases may require longer.
Cardiac evaluation
Obtain an ECG and consider cardiac troponin measurement in patients with significant exposure, chest pain, severe symptoms, or other cardiac concerns.
Carbon monoxide–associated myocardial injury has important prognostic implications.
Hyperbaric oxygen
Hyperbaric oxygen therapy may be considered in selected cases.
Potential indications include:
- COHb greater than approximately 25–30%.
- Loss of consciousness.
- Significant neurologic impairment.
- Severe metabolic acidosis.
- Evidence of myocardial ischemia or other cardiac injury.
- Other severe clinical findings.
Important evidence limitation
Randomized trials have produced inconsistent results regarding prevention of delayed neurologic injury.
Therefore, the decision should not rely solely on a COHb threshold.
Hyperbaric oxygen is a specialist decision based on clinical severity, patient circumstances, transport risks, and availability.
Pregnancy
Pregnancy generally warrants a lower threshold for considering hyperbaric oxygen because fetal carbon monoxide clearance is slower than maternal clearance.
9. Cyanide poisoning
Cyanide may be generated during combustion of nitrogen-containing materials.
Its principal toxic action is inhibition of mitochondrial cytochrome c oxidase.
This prevents normal cellular utilization of oxygen.
Clinical manifestations
Severe cyanide poisoning may produce:
- Altered mental status.
- Seizures.
- Profound hypotension.
- Metabolic acidosis.
- Cardiac dysrhythmias.
- Cardiovascular collapse.
Lactate
Markedly elevated lactate is a useful diagnostic clue.
The FDA-approved Cyanokit labeling identifies plasma lactate of at least 10 mmol/L as particularly suggestive in smoke-inhalation victims.
This threshold is higher than that often considered concerning after isolated cyanide exposure because carbon monoxide and other fire-related injuries can also increase lactate.
Important limitations
Lactate is not a cyanide-specific test.
Severe burns, shock, seizures, hypoxia, and other causes of impaired perfusion can also produce lactic acidosis.
A lactate below 10 mmol/L does not absolutely exclude cyanide poisoning.
Cyanide concentrations
Blood cyanide measurements are generally unavailable rapidly enough to guide emergency care.
Treatment must not be delayed while awaiting cyanide results when clinical suspicion is strong.
10. Hydroxocobalamin
Hydroxocobalamin is the preferred specific antidote for strongly suspected or confirmed cyanide poisoning.
It binds cyanide to form cyanocobalamin, which is eliminated through the kidneys.
Indications
Consider immediate hydroxocobalamin treatment after a significant smoke exposure when findings strongly suggest cyanide poisoning, particularly:
- Cardiac arrest or profound cardiovascular instability.
- Unexplained severe hypotension.
- Major neurologic impairment after enclosed-space fire exposure.
- Severe lactic acidosis.
- A combination of soot exposure, altered consciousness, and substantial systemic toxicity.
Adult dose
5 g intravenously over approximately 15 minutes.
A second 5 g dose may be administered according to severity and clinical response.
The usual maximum recommended total dose is 10 g.
Pediatric dose
70 mg/kg intravenously, maximum 5 g per dose.
A second dose may be given when clinically indicated.
Important safety consideration
Hydroxocobalamin is not necessary for every smoke-exposed patient.
Empirical treatment in patients with little evidence of systemic cyanide toxicity has an uncertain benefit-risk balance.
Observational studies have found an association between hydroxocobalamin administration and acute kidney injury.
These studies cannot fully establish whether the drug caused the injury because treated patients were often more severely ill.
Nevertheless, they support avoiding indiscriminate administration.
Additional effects
Hydroxocobalamin commonly produces temporary red discoloration of the skin and urine.
It can interfere with some laboratory assays and may trigger dialysis-machine blood-leak alarms.
Clinicians should inform laboratory and dialysis teams when the drug has been administered.
11. Sodium thiosulfate and historical cyanide antidotes
Sodium thiosulfate
Sodium thiosulfate promotes conversion of cyanide into thiocyanate, a less toxic compound.
It has a slower onset of action than hydroxocobalamin.
It may have a role in selected cases when hydroxocobalamin is unavailable or as part of specialist-directed treatment.
Nitrites
Amyl nitrite and sodium nitrite were components of historical cyanide-antidote kits.
They generate methemoglobin, which can bind cyanide.
However, inducing methemoglobinemia decreases functional oxygen-carrying capacity.
Smoke-inhalation concern
Patients exposed to fires may already have impaired oxygen delivery due to carbon monoxide poisoning.
Nitrite-based antidotes are therefore generally undesirable in smoke-inhalation victims when hydroxocobalamin is available.
Historical correction
The old recommendation to administer sodium thiosulfate empirically to every unconscious fire victim should be replaced with clinical assessment for cyanide toxicity and prompt hydroxocobalamin when strongly indicated.
12. Airway management
The need for early intervention
Progressive upper-airway swelling can turn a manageable airway into a difficult or impossible airway.
Early intubation is appropriate when important airway compromise is present or strongly anticipated.
Concerning findings
Indications for urgent airway evaluation include:
- Stridor.
- Progressive oropharyngeal swelling.
- Respiratory distress.
- Hypoxemia or hypercapnia.
- Inability to protect the airway.
- Severe impairment of consciousness.
- Significant facial or neck burns threatening airway patency.
Early intubation may also be appropriate when deterioration during prolonged transport is likely.
Avoiding unnecessary intubation
Not every patient with soot, hoarseness, singed nasal hairs, or a history of smoke exposure requires intubation.
These findings must be interpreted together with airway examination, clinical course, and anticipated access to advanced airway care.
Airway visualization
Flexible nasolaryngoscopy may help evaluate upper-airway injury in suitable patients.
Bronchoscopy can assess lower-airway injury once the airway is secure.
Important principle
Do not delay intubation in a patient with impending airway obstruction merely to obtain imaging or bronchoscopy.
Conversely, unnecessary intubation introduces risks, including ventilator-associated complications.
13. Bronchoscopy
Flexible bronchoscopy is useful for confirming and characterizing lower-airway inhalation injury.
It may identify:
- Mucosal erythema.
- Edema.
- Ulceration.
- Soot deposition.
- Necrotic tissue.
- Obstructive secretions or casts.
Grading
Several bronchoscopic grading systems are used.
Their value for precisely predicting prognosis or determining all treatments remains imperfect.
Therapeutic bronchoscopy
Bronchoscopy may help remove obstructive secretions or casts in selected patients.
Repeated bronchoscopic treatment is primarily a specialist strategy for more severe injury.
Clinical limitation
Routine bronchoscopy is not required for every patient with minor smoke exposure.
14. Ventilation and respiratory support
Oxygen
Give high-concentration oxygen initially when systemic toxic-gas exposure is possible.
Subsequent oxygen delivery should be guided by oxygenation and the clinical condition.
Bronchospasm
Inhaled bronchodilators such as albuterol may be used for wheezing and bronchospasm.
Humidification and airway clearance
Humidified respiratory support, suction, chest physiotherapy, and appropriate mobilization can help manage secretions.
Mechanical ventilation
Patients with respiratory failure may require invasive mechanical ventilation.
Lung-protective ventilation strategies are preferred for significant lung injury and ARDS.
Pulmonary edema
Manage noncardiogenic pulmonary edema with appropriate ventilatory support.
Careful fluid management is important because excessive fluid administration may worsen pulmonary complications.
15. Nebulized heparin and N-acetylcysteine
Airway inflammation may lead to fibrin-rich casts and tenacious secretions.
Nebulized heparin
Nebulized heparin has been investigated to reduce obstructive cast formation.
N-acetylcysteine
Nebulized N-acetylcysteine may assist mucus clearance.
However, it can provoke bronchospasm in susceptible patients.
Evidence
Some studies and expert protocols support these therapies for moderate or severe inhalation injury.
Other research has produced inconsistent findings.
The optimal dose, combination, patient selection, and clinical benefit remain uncertain.
Practical recommendation
Nebulized heparin and N-acetylcysteine are not required for every smoke-inhalation patient.
Their use should follow appropriate burn-center or intensive-care protocols.
16. Corticosteroids and antibiotics
Corticosteroids
Routine systemic corticosteroids are not recommended solely to treat smoke inhalation injury.
There is insufficient evidence that they improve outcomes.
They may increase complications in certain circumstances.
Important exception
Corticosteroids may still be appropriate for an independent condition, such as a clinically important asthma or COPD exacerbation.
Antibiotics
Routine prophylactic systemic antibiotics are not recommended.
Smoke-inhalation injury initially causes chemical inflammation rather than bacterial infection.
Infection
Secondary bacterial pneumonia can develop during hospitalization, particularly in patients requiring mechanical ventilation.
Antibiotics should be used when bacterial infection is clinically suspected or established.
17. Diagnostic evaluation
Initial assessment
Evaluate airway patency, breathing, circulation, consciousness, burns, and associated trauma.
Obtain details about the fire location, duration of exposure, ventilation, and materials involved.
Essential investigations in significant exposure
Consider:
- Blood gas with co-oximetry.
- Carboxyhemoglobin.
- Electrolytes.
- Glucose.
- Creatinine.
- Lactate.
- ECG.
Additional investigations
Troponin is appropriate when cardiac injury is possible.
Chest radiography is useful in patients with respiratory symptoms or significant exposures.
Chest imaging limitation
A normal early chest radiograph does not exclude inhalation injury.
Methemoglobin
Methemoglobin should be measured when there is a specific reason to suspect methemoglobinemia, such as relevant chemical exposure or unexplained cyanosis.
Routine methemoglobin testing is not necessary after every ordinary smoke exposure.
Cyanide measurement
Cyanide testing may assist later confirmation, but it should not delay treatment.
Other investigations
Evaluate for traumatic injury, intoxication, intracranial injury, or other causes of altered mental status when clinically indicated.
18. Shock and cardiovascular complications
Causes of hypotension
Hypotension after smoke exposure may result from cyanide poisoning, severe burns, dehydration, myocardial dysfunction, hemorrhage, or another cause of shock.
Fluids
Provide appropriately titrated isotonic crystalloid when indicated.
Patients with extensive burns require structured burn-resuscitation management.
Avoid excessive fluid administration, particularly when pulmonary injury is present.
Vasopressors
Persistent vasodilatory shock may require norepinephrine after appropriate initial management.
The older routine recommendation to begin dopamine is no longer a preferred default.
Arrhythmias
Treat clinically important dysrhythmias according to current advanced life support guidelines.
Correct hypoxemia, acid-base abnormalities, and electrolyte disturbances.
Historical correction
Routine use of lidocaine for ventricular ectopy or bretylium for ventricular tachycardia should not be carried forward.
Treatment should be determined by the rhythm, hemodynamic status, and current resuscitation protocols.
19. Pregnancy and lactation
Pregnancy
Carbon monoxide readily crosses the placenta.
Fetal carbon monoxide elimination is slower than maternal elimination.
Maternal symptoms and COHb concentrations may therefore underestimate fetal risk.
Evaluation
Pregnant patients with significant smoke exposure require prompt maternal assessment and appropriate obstetric involvement.
Oxygen
Administer high-concentration oxygen when carbon monoxide exposure is suspected.
Hyperbaric oxygen
Hyperbaric oxygen deserves particular consideration in pregnancy, even when maternal findings appear less severe.
Decisions should involve clinicians familiar with carbon monoxide poisoning and obstetric care.
Cyanide poisoning
When severe cyanide poisoning is strongly suspected, necessary antidotal treatment should not be withheld because of pregnancy.
Maternal stabilization is the priority.
Breastfeeding
There is no general requirement to interrupt breastfeeding solely because a patient experienced smoke exposure.
However, the mother’s clinical condition, specific chemical exposures, and medications used during treatment must be considered.
20. Observation, admission, and burn-center referral
Mild smoke exposure
Patients with brief exposure, no significant symptoms, reassuring examination, and no evidence of systemic poisoning may be suitable for discharge after appropriate observation.
Significant enclosed-space exposure
A prolonged or high-risk enclosed-space exposure requires careful evaluation, even if the initial examination is relatively reassuring.
Suspected inhalation injury
The American Burn Association recommends immediate burn-center consultation, with consideration of transfer, for patients with suspected inhalation injury.
Patients with facial flash burns, singed facial hair, or smoke exposure but without established inhalation injury may also benefit from consultation.
Hospital admission
Admission is appropriate for:
- Significant airway symptoms.
- Progressive hoarseness or swelling.
- Hypoxemia.
- Bronchospasm requiring ongoing therapy.
- Pulmonary infiltrates or edema.
- Significant carbon monoxide poisoning.
- Suspected cyanide toxicity.
- Altered mental status.
- Cardiovascular complications.
- Major associated burns or trauma.
Intensive care
ICU admission is appropriate for threatened airway patency, respiratory failure, severe toxic-gas poisoning, shock, or major associated burn injury.
Observation duration
A fixed six-hour observation period is not universally adequate or necessary.
Observation should be based on exposure history, evolving airway findings, respiratory status, systemic poisoning risk, and clinical recovery.
21. Discharge and follow-up
Before discharge, the patient should have stable breathing and circulation, reassuring neurologic status, and no evidence of evolving airway or pulmonary injury requiring further observation.
Return precautions
Patients should seek urgent reassessment for:
- New or worsening shortness of breath.
- Progressive hoarseness.
- Stridor.
- Chest pain.
- Confusion.
- Syncope.
- Persistent or worsening cough.
- Fever or other signs suggesting later pulmonary complications.
Carbon monoxide follow-up
Delayed neurologic complications can develop after apparent initial recovery.
Symptoms may include memory problems, mood or personality changes, difficulty concentrating, and movement abnormalities.
The CDC recommends follow-up examination, including neurologic reassessment, in approximately two weeks after CO poisoning.
Long-term pulmonary effects
Some patients experience persistent cough, airway hyperreactivity, reduced exercise tolerance, or other pulmonary symptoms after significant inhalation injury.
Pulmonary follow-up is appropriate when symptoms persist.
22. Prognosis
Mild exposure
Most minor exposures resolve without permanent complications.
Severe airway injury
Progressive edema can cause acute respiratory obstruction.
Prompt recognition and appropriate airway management improve outcomes.
Lower-respiratory injury
Severe chemical injury can lead to prolonged mechanical ventilation, ARDS, and secondary pulmonary complications.
Carbon monoxide poisoning
Long-term cognitive or neurologic symptoms may develop even after the acute symptoms have resolved.
Cyanide poisoning
Severe untreated cyanide poisoning can cause rapid cardiovascular collapse and death.
Overall outcome
Prognosis is influenced by the severity of inhalation injury, duration of exposure, associated burns or trauma, systemic poisoning, and underlying medical conditions.
23. Clinical pitfalls
Assuming smoke inhalation means carbon monoxide poisoning alone. Cyanide, thermal injury, and chemical lung injury may coexist.
Relying on visible facial burns. Serious airway injury can occur without external burns.
Automatically intubating everyone with singed nasal hair. Clinical findings and progression must guide airway decisions.
Delaying intubation when airway obstruction is developing. Progressive edema can make later intubation much more difficult.
Relying on normal pulse oximetry. Conventional pulse oximeters do not reliably detect carbon monoxide poisoning.
Assuming a low COHb excludes prior serious exposure. Oxygen treatment and sampling delay can lower the measured concentration.
Using COHb alone to decide hyperbaric treatment. Neurologic, cardiac, acid-base, pregnancy, and other clinical findings matter.
Assuming hyperbaric oxygen prevents all delayed neurologic complications. The evidence remains conflicting.
Treating every smoke victim with hydroxocobalamin. Empirical use without strong cyanide suspicion may expose patients to unnecessary risk.
Waiting for a cyanide concentration before treating severe suspected poisoning. Laboratory confirmation is usually too slow.
Using nitrite antidotes routinely. Additional methemoglobinemia can worsen oxygen transport when carbon monoxide poisoning is present.
Missing an elevated lactate. Lactate of at least 10 mmol/L after significant smoke exposure should increase suspicion of cyanide poisoning.
Assuming a normal initial chest radiograph excludes lung injury. Radiographic abnormalities may develop later.
Giving routine corticosteroids or prophylactic antibiotics. Neither is recommended solely for inhalation injury.
Using nebulized heparin or N-acetylcysteine in every case. These are selected specialist therapies with an evolving evidence base.
Using outdated dopamine, lidocaine, or bretylium protocols. Management should follow contemporary shock and resuscitation guidance.
Failing to refer suspected inhalation injury. Burn-center consultation is recommended.
Forgetting delayed neurologic assessment after carbon monoxide poisoning. Patients may develop symptoms after discharge.
Key clinical conclusions
Smoke inhalation injury is a combination of potential airway injury, chemical lung damage, and systemic poisoning.
Immediate treatment includes removal from exposure, 100% oxygen, assessment of airway patency, and prompt resuscitation.
Carbon monoxide poisoning requires co-oximetry and clinical assessment. Hyperbaric oxygen may be considered in selected severe cases and deserves particular consideration during pregnancy.
Hydroxocobalamin is the preferred antidote for strongly suspected cyanide poisoning, but it should not be administered automatically after every smoke exposure.
Airway management requires balancing two risks: failure to recognize progressive swelling and unnecessary intubation of patients with mild exposure.
Supportive respiratory care is the foundation of treatment. Routine systemic corticosteroids, prophylactic antibiotics, historical nitrite-antidote regimens, and obsolete antiarrhythmic protocols should not be carried forward.
The most important principle is repeated reassessment: smoke-inhalation injury may progress after an initially reassuring examination.